![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2019 18:20 | He did, Ged. Herb, there's more on the following link if you want to get up to date. | ![]() lr2 | |
17/10/2019 18:14 | Thanks LR2 Didn't he say not in today's interview, Herb? | ![]() ged5 | |
17/10/2019 18:10 | Should this be RNS'd? | herb clark | |
17/10/2019 17:37 | TexRAD Research+ In response to requests from users for more functionality to meet the changing needs of imaging research, we are delighted to announce a new add-on: TexRAD Research+. This offers important additional information, providing all of the patented filtration-histogram features of TexRAD Research, with the additional measurement parameters of GLCM (Grey Level Co-occurence Matrix) and shape. TexRAD Research + offers a platform for comprehensive radiomics analysis. TexRAD Research+ is available as a premium add-on to existing TexRAD users or can be specified as a complete package by new users. For more information, visit the TexRAD pages of our website: TexRAD Research TexRAD Research+ is available to order now. Contact us to find out more How to Order Good to see they are charging for it and it can be ordered now. | ![]() lr2 | |
17/10/2019 15:21 | 'Bleepa @BleepaMe "We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives at NHS Expo. The feedback is that Bleepa® clearly has applications in individual hospital settings but also in community and cross site clinical sett' | ![]() hazl | |
17/10/2019 14:15 | Ged, exactly. If bleepa gains traction in the U.K. I expect it will be taken out by a large global interest. Assuming it's IP is protected and it is unique. Exciting times ahead. Tidy, yes, placing stock is the issue currently. | ![]() ducatiman | |
17/10/2019 14:11 | I reckon a bit of the last placing stock is being flipped. Cant be much left now. | tidy 2 | |
17/10/2019 14:08 | Bleepa® clearly has applications in individual hospital settings but also in community and cross site clinical settings. Who's been for a scan and then an appointment with a doctor? Doctor refers you to the Physio after several weeks waiting for the scan results. The appointment with the Physio is delayed for some time, because they're waiting for results from the doctor who's too overburdened to send the notes/scan promptly. Isn't this where Bleepa comes into play? So the radiologist, GP and Physio all need Bleepa for this to work. Well that's 30 quid a month and I'm just one patient. :-) | ![]() ged5 | |
17/10/2019 13:50 | Dave, no worries. share price should climb steadily from here. The news is very encouraging. | ![]() ducatiman | |
17/10/2019 13:31 | Don't forget..... 'The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa(R) pilot schemes in the near future.' which suggests more news in the future,perhaps! | ![]() hazl | |
17/10/2019 13:30 | So what is meant by community and cross site clinical settings? | ![]() ged5 | |
17/10/2019 13:29 | BLEEPA Tweet "We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives at NHS Expo. The feedback is that Bleepa® clearly has applications in individual hospital settings but also in community and cross site clinical settings."ow.ly/NKYW | tidy 2 | |
17/10/2019 13:28 | BLEEPA Tweet"We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives at NHS Expo. The feedback is that Bleepa® clearly has applications in individual hospital settings but also in community and cross site clinical settings."ow.ly/NKYW | tidy 2 | |
17/10/2019 13:08 | New thread? I can't see one. | ![]() ged5 | |
17/10/2019 13:08 | hazl Just back online. I'll update it this evening. Not sure I want it as long as the other thread but more upto date news | ![]() dave4545 | |
17/10/2019 12:43 | Bleepa will help get rid of NHS waiting times which is one of the main aims of the government | tidy 2 | |
17/10/2019 12:36 | Looks like we've lost hazl to the other new thread. How sad. | ![]() ducatiman | |
17/10/2019 11:54 | Thanks LR2. Added to header. Was it a lie in the first place? Anyway not done much for the share price Still a lot of hope in that interview. | ![]() ged5 | |
17/10/2019 11:36 | He actually says 'as a radiologist I would have loved to have seen that' in that clip. Doubling down on that lie then! | ![]() dplewis1 | |
17/10/2019 11:29 | Tom Oakley latest chat. | ![]() lr2 | |
17/10/2019 11:18 | Hazl, post 3681, I can't get access to that link. What settings does it mention, please? | ![]() ged5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions